Dr Rachael Richardson is currently a Principal Research Fellow at the Bionics Institute. The main goal of her research is to develop innovative strategies to improve precision of neural stimulation.
Rachael’s research is examining whether optogenetic-based stimulation strategies can significantly improve the precision of nerve activation in the cochlea and whether this will result in a meaningful difference to the way people hear sound.
Another major focus of Rachael’s research is to protect and/or restore hearing. Rachael is employing gene therapy and nano-technology-inspired drug delivery techniques to introduce therapeutics into the cochlea for sensory cell regeneration and repair. These techniques have the potential to improve the outcomes achieved with cochlear implantation or even restore hearing by repopulating the damaged sensory region of the cochlea with new cells.
Rachael completed a BSc degree at the University of Melbourne. Her BSc(Hons) and PhD were undertaken at the Walter and Eliza Hall Institute of Medical Research, Department of Cancer and Haematology, supervised by Prof Doug Hilton. Rachael has worked at the Bionics Institute since 2001.
Find out more about Rachael Richardson's experience
Rachael Richardson's highlights
FEATURED Journal article
Engineering Biocoatings To Prolong Drug Release from Supraparticles
Read moreRachael Richardson's selected work
Projects
Displaying the 2 most recent projects by Rachael Richardson.
Project Types
2
Research Grant
Scholarly Works
Displaying the 37 most recent scholarly works by Rachael Richardson.
Credentials
Positions
Honorary
Medical Bionics Department
Honorary
Medical Bionics Department
Honorary
Otolaryngology